31,695 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Purchased by Aigen Investment Management LP
Aigen Investment Management LP bought a new position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) during the third quarter, Holdings Channel reports. The fund bought 31,695 shares of the biopharmaceutical company’s stock, valued at approximately $385,000. A number of other institutional investors also recently bought and sold shares of the company. Vanguard […]
More Stories
White House Says Cuban Regime Is ‘Bound to Fall’
By Travis Gillmore WASHINGTON—White House press secretary Karoline Leavitt addressed the situation in Cuba, where the population of nearly 10...
Fed Still Forecasts Lower Interest Rates This Year Despite Iran Conflict
By Andrew Moran Federal Reserve officials anticipate lower interest rates this year, despite the Iranian conflict clouding the economic outlook,...
Vance to Lead US Delegation to Pakistan for Peace Talks With Iran
By Savannah Hulsey Pointer Vice President JD Vance and a team of negotiators are headed to Pakistan for peace talks...
How the High-Stakes Rescue Mission in Iran Unfolded
By John Haughey President Donald Trump was assured by the Pentagon and Central Intelligence Agency that the assembled array of...
Earnings Season Is About to Begin, and I Expect Positive Changes
By Louis Navellier We’re approaching another earnings season, starting in mid-April, when many of our stocks shine the brightest. Some...
These Detransitioners Sued for Medical Malpractice, but Will They Get Their Day in Court
By Darlene McCormick Sanchez Prisha Mosley thought that she would get her day in court when the North Carolina Legislature...